Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2012

01-07-2012 | Laboratory Investigation

Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells

Authors: Martin Hefti, Ina Albert, Vera Luginbuehl

Published in: Journal of Neuro-Oncology | Issue 3/2012

Login to get access

Abstract

Epileptic seizures are among the presenting clinical signs of malignant glioma patients, frequently necessitating treatment with antiepileptic drugs (AEDs). The efficacy of 5-aminolevulinic acid (5-ALA)-based intraoperative fluorescence-guided surgery and photodynamic therapy (PDT) in glioblastoma multiforme (GBM) patients depends on the specific accumulation and total amount of intracellularly synthesized protoporphyrin IX (PpIX) in tumour cells. In this study, we investigated the effect of the AEDs phenytoin (PHY) and levetiracetam (LEVE) on 5-ALA-induced PpIX accumulation in two glioma cell lines (U373 MG and U-87 MG) and primary GBM cells isolated from a human biopsy. After treatment with PHY and LEVE for three days cells were incubated with 1 mM 5-ALA for 4 h and PpIX accumulation was determined by fluorescence measurement. We observed a decrease in PpIX synthesis of up to 55 ± 12 % in primary GBM cells after incubation with phenytoin. This reduction was dose-dependent for all tested cell lines and primary GBM cells. LEVE on the other hand did not alter PpIX concentration in GBM cells. PDT was performed in vitro by irradiating the GBM cells with light doses from 0.5 to 10 J cm−2 at 627 nm after AED and 5-ALA treatment. Although less PpIX accumulated in PHY-treated cells, efficacy of PDT was not affected. We assume that damage to the mitochondrial membrane by PHY inhibits PpIX synthesis in vitro, because we showed mitochondrial dysfunction as a result of reduced mitochondrial membrane potential in PHY-treated cells. No change in glutathione status was observed. To evaluate further the effect of PHY on PpIX fluorescence, and to establish its significance in clinical practice, animal and clinical studies are required, because the results presented here imply PHY may reduce intracellular accumulation of PpIX in patients with high-grade gliomas.
Literature
1.
go back to reference Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Aboukhalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52(7):717–724PubMedCrossRef Moots PL, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Aboukhalil B (1995) The course of seizure disorders in patients with malignant gliomas. Arch Neurol 52(7):717–724PubMedCrossRef
2.
go back to reference Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase II study. Neurosurgery 65(6):1070–1076PubMedCrossRef Nabavi A, Thurm H, Zountsas B, Pietsch T, Lanfermann H, Pichlmeier U, Mehdorn M (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase II study. Neurosurgery 65(6):1070–1076PubMedCrossRef
3.
go back to reference Stander M, Dichgans J, Weller M (1998) Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells. J Neurooncol 37(3):191–198PubMedCrossRef Stander M, Dichgans J, Weller M (1998) Anticonvulsant drugs fail to modulate chemotherapy-induced cytotoxicity and growth inhibition of human malignant glioma cells. J Neurooncol 37(3):191–198PubMedCrossRef
4.
go back to reference Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A (2010) Efficacy and safety of levetiracetam in patients with glioma a clinical prospective study. Arch Neurol 67(3):343–346PubMedCrossRef Rosati A, Buttolo L, Stefini R, Todeschini A, Cenzato M, Padovani A (2010) Efficacy and safety of levetiracetam in patients with glioma a clinical prospective study. Arch Neurol 67(3):343–346PubMedCrossRef
5.
go back to reference Usery JB, Michael LM 2nd, Sills AK, Finch CK (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 99(2):251–260PubMedCrossRef Usery JB, Michael LM 2nd, Sills AK, Finch CK (2010) A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures. J Neurooncol 99(2):251–260PubMedCrossRef
6.
go back to reference Santos NAG, Medina WSG, Martins NM, Mingatto FE, Curti C, Santos AC (2008) Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 22(5):1143–1152PubMedCrossRef Santos NAG, Medina WSG, Martins NM, Mingatto FE, Curti C, Santos AC (2008) Aromatic antiepileptic drugs and mitochondrial toxicity: effects on mitochondria isolated from rat liver. Toxicol In Vitro 22(5):1143–1152PubMedCrossRef
7.
go back to reference Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJJ, Perstin J, Preston TJ, Wiley MJ, Wong AW (2009) Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 108(1):4–18PubMedCrossRef Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJJ, Perstin J, Preston TJ, Wiley MJ, Wong AW (2009) Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci 108(1):4–18PubMedCrossRef
8.
go back to reference Meyer RP, Knoth R, Schiltz E, Volk B (2001) Possible function of astrocyte cytochrome p450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures. Exp Neurol 167(2):376–384PubMedCrossRef Meyer RP, Knoth R, Schiltz E, Volk B (2001) Possible function of astrocyte cytochrome p450 in control of xenobiotic phenytoin in the brain: in vitro studies on murine astrocyte primary cultures. Exp Neurol 167(2):376–384PubMedCrossRef
9.
go back to reference Knupfer H, Stanitz D, Preiss R (2006) CYP2C9 polymorphisms in human tumors. Anticancer Res 26(1):299–305PubMed Knupfer H, Stanitz D, Preiss R (2006) CYP2C9 polymorphisms in human tumors. Anticancer Res 26(1):299–305PubMed
10.
go back to reference Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W (2002) Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97(4):970–976PubMedCrossRef Olzowy B, Hundt CS, Stocker S, Bise K, Reulen HJ, Stummer W (2002) Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. J Neurosurg 97(4):970–976PubMedCrossRef
11.
go back to reference Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef
12.
go back to reference Ennis SR, Novotny A, Xiang J, Shakui P, Masada T, Stummer W, Smith DE, Keep RF (2003) Transport of 5-aminolevulinic acid between blood and brain. Brain Res 959(2):226–234PubMedCrossRef Ennis SR, Novotny A, Xiang J, Shakui P, Masada T, Stummer W, Smith DE, Keep RF (2003) Transport of 5-aminolevulinic acid between blood and brain. Brain Res 959(2):226–234PubMedCrossRef
13.
go back to reference Novotny A, Xiang J, Stummer W, Teuscher NS, Smith DE, Keep RF (2000) Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem 75(1):321–328PubMedCrossRef Novotny A, Xiang J, Stummer W, Teuscher NS, Smith DE, Keep RF (2000) Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus. J Neurochem 75(1):321–328PubMedCrossRef
14.
go back to reference Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79(12):2282–2308PubMedCrossRef Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79(12):2282–2308PubMedCrossRef
15.
go back to reference Kondo M, Hirota N, Takaoka T, Kajiwara M (1993) Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9(1):95–105PubMedCrossRef Kondo M, Hirota N, Takaoka T, Kajiwara M (1993) Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell Biol Toxicol 9(1):95–105PubMedCrossRef
16.
go back to reference Chang YZ, Qian ZM, Du JR, Zhu L, Xu Y, Li LZ, Wang CY, Wang Q, Ge XH, Ho KP, Niu L, Ke Y (2007) Ceruloplasmin expression and its role in iron transport in C6 cells. Neurochem Int 50(5):726–733PubMedCrossRef Chang YZ, Qian ZM, Du JR, Zhu L, Xu Y, Li LZ, Wang CY, Wang Q, Ge XH, Ho KP, Niu L, Ke Y (2007) Ceruloplasmin expression and its role in iron transport in C6 cells. Neurochem Int 50(5):726–733PubMedCrossRef
17.
go back to reference Dysart JS, Singh G, Patterson MS (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 81(1):196–205PubMedCrossRef Dysart JS, Singh G, Patterson MS (2005) Calculation of singlet oxygen dose from photosensitizer fluorescence and photobleaching during mTHPC photodynamic therapy of MLL cells. Photochem Photobiol 81(1):196–205PubMedCrossRef
18.
go back to reference Liao H, Noguchi M, Maruyama T, Muragaki Y, Kobayashi E, Iseki H, Sakuma I (2012) An integrated diagnosis and therapeutic system using intra-operative 5-aminolevulinic-acid-induced fluorescence guided robotic laser ablation for precision neurosurgery. Med Image Anal 16(3):754–766PubMedCrossRef Liao H, Noguchi M, Maruyama T, Muragaki Y, Kobayashi E, Iseki H, Sakuma I (2012) An integrated diagnosis and therapeutic system using intra-operative 5-aminolevulinic-acid-induced fluorescence guided robotic laser ablation for precision neurosurgery. Med Image Anal 16(3):754–766PubMedCrossRef
19.
go back to reference Utsuki S, Oka H, Sato S, Shimizu S, Suzuki S, Tanizaki Y, Kondo K, Miyajima Y, Fujii K (2007) Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) 47(5):210–213 (discussion 213–214)CrossRef Utsuki S, Oka H, Sato S, Shimizu S, Suzuki S, Tanizaki Y, Kondo K, Miyajima Y, Fujii K (2007) Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo) 47(5):210–213 (discussion 213–214)CrossRef
20.
go back to reference Hefti M, Holenstein F, Albert I, Looser H, Luginbuehl V (2011) Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochem Photobiol 87(1):235–241PubMedCrossRef Hefti M, Holenstein F, Albert I, Looser H, Luginbuehl V (2011) Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity. Photochem Photobiol 87(1):235–241PubMedCrossRef
21.
go back to reference Etminan N, Peters C, Ficnar J, Anlasik S, Bunemann E, Slotty PJ, Hanggi D, Steiger HJ, Sorg RV, Stummer W (2011) Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. J Neurosurg 115(2):281–288PubMedCrossRef Etminan N, Peters C, Ficnar J, Anlasik S, Bunemann E, Slotty PJ, Hanggi D, Steiger HJ, Sorg RV, Stummer W (2011) Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. J Neurosurg 115(2):281–288PubMedCrossRef
22.
go back to reference Furre I, Møller M, Shahzidi S, Nesland J, Peng Q (2006) Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis 11(11):2031–2042PubMedCrossRef Furre I, Møller M, Shahzidi S, Nesland J, Peng Q (2006) Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis 11(11):2031–2042PubMedCrossRef
23.
go back to reference Lowndes HE, Beiswanger CM, Philbert MA, Reuhl KR (1994) Substrates for neural metabolism of xenobiotics in adult and developing brain. Neurotoxicology 15(1):61–73PubMed Lowndes HE, Beiswanger CM, Philbert MA, Reuhl KR (1994) Substrates for neural metabolism of xenobiotics in adult and developing brain. Neurotoxicology 15(1):61–73PubMed
24.
go back to reference Mariotti V, Melissari E, Amar S, Conte A, Belmaker RH, Agam G, Pellegrini S (2010) Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays. Exp Biol Med 235(3):300–310CrossRef Mariotti V, Melissari E, Amar S, Conte A, Belmaker RH, Agam G, Pellegrini S (2010) Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays. Exp Biol Med 235(3):300–310CrossRef
25.
go back to reference Gallagher EP, Sheehy KM (2001) Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices. Toxicol Sci 59(1):118–126PubMedCrossRef Gallagher EP, Sheehy KM (2001) Effects of phenytoin on glutathione status and oxidative stress biomarker gene mRNA levels in cultured precision human liver slices. Toxicol Sci 59(1):118–126PubMedCrossRef
26.
go back to reference Nicolazzo JA, Steuten JA, Charman SA, Taylor N, Davies PJ, Petrou S (2010) Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy. Clin Exp Pharmacol Physiol 37(5–6):647–649PubMedCrossRef Nicolazzo JA, Steuten JA, Charman SA, Taylor N, Davies PJ, Petrou S (2010) Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy. Clin Exp Pharmacol Physiol 37(5–6):647–649PubMedCrossRef
27.
go back to reference Ramsay RE, Hammond EJ, Perchalski RJ, Wilder BJ (1979) Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 36(9):535–539PubMedCrossRef Ramsay RE, Hammond EJ, Perchalski RJ, Wilder BJ (1979) Brain uptake of phenytoin, phenobarbital, and diazepam. Arch Neurol 36(9):535–539PubMedCrossRef
28.
go back to reference Sironi VA, Ravagnati L, Ettorre G, Cabrini GP, Marossero F (1982) Differences between the concentrations of antiepileptic drugs in normal and pathological human brain. Eur J Clin Pharmacol 22(5):447–449PubMedCrossRef Sironi VA, Ravagnati L, Ettorre G, Cabrini GP, Marossero F (1982) Differences between the concentrations of antiepileptic drugs in normal and pathological human brain. Eur J Clin Pharmacol 22(5):447–449PubMedCrossRef
Metadata
Title
Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells
Authors
Martin Hefti
Ina Albert
Vera Luginbuehl
Publication date
01-07-2012
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2012
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-012-0857-9

Other articles of this Issue 3/2012

Journal of Neuro-Oncology 3/2012 Go to the issue